Kancera AB operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other
pharmaceutical manufacturers in Europe:
sales of 277,780.14 Swedish Kronor [US$32,191.94 ]
Hemcheck Sweden AB
(306,810.00 Swedish Kronor [US$35,556.21 ]
Index Pharmaceuticals Holding Ab
(35,000.00 Swedish Kronor [US$4,056.15 ]
Sales fell dramatically in 2020:
Kancera AB reported sales of SEK 90,000.00 (US$10.43 thousand)
December of 2020.
decrease of 97.2%
versus 2019, when the company's sales were SEK 3.22 million.